Brian Nowosielski

With the emergence of increased GLP-1 use and alternative PBM models, Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, joined Drug Topics to discuss current trends in drug benefit design.

Researchers explored the prevalence of obesity-related complications and obesity medication use in US children and young adults with obesity.

Researchers presented an abstract describing current racial disparities in CGM access and wear time to better inform quality improvement efforts.

Pharmaceutical Strategies Group experts joined Drug Topics to discuss the role GLP-1s play in drug benefit design.

Researchers explored the impact of a $0 copay program on hemoglobin A1c levels in patients with type 2 diabetes who were also insured by Blue Cross and Blue Shield of Louisiana.

In a retrospective study of obesity-related mortality, researchers explored US death trends before, during, and after the COVID-19 pandemic.

Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss how the role of PBMs in plan design is evolving.

Tara Pfund, PharmD, chief strategy officer with the Cascadia Pharmacy Group, discusses a variety of ways community pharmacists can expand services and support clinical reimbursement.

Abstract researchers explored whether or not a pharmacist could serve as the lead of a diabetes coaching program, aiming to reduce medical expenditures and A1C levels for at-risk patients.

John Hill, MBAHCM, and Pooja Babbrah, MBA, from the National Council for Prescription Drug Programs, discuss their organization’s strategic plan for advancing the pharmacy profession.

Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss the 2025 Trends in Drug Benefit Design Report and how it will impact pharmacists.

Researchers explored pharmacists’ ability to collaborate with other health care professionals in single-disciplinary outpatient practice environments.

Researchers reviewed current understandings of the role vaccines play in dermatology, what gaps persist, and what future research is necessary.

Researchers conducted a narrative review to explore the possibility of integrating social perspectives and aspects into dermatological care and research.

Amid the continuously evolving role of pharmacists in today’s health care landscape, independent owners like Amina Abubakar, PharmD, AAHIVP, are advancing the profession through innovation.

Louisiana opened the investigation upon discovering a CVS text message campaign sent out to patients asking them to advocate against proposed legislation.

Researchers explored the incidence of pneumococcal hemolytic uremic syndrome in children living in Sweden from January 2009 to December 2024.

The review explored the “emerging” term gut-skin axis and aimed to decipher the bidirectional signaling of the skin and gastrointestinal tract during homeostatic and disease states.

Independent pharmacy owner and educator Amina Abubakar, PharmD, AAHIVP, shares her hopes for the future of the pharmacy industry and advice for the next generation of pharmacists.

Researchers conducted a systematic review and meta-analysis to estimate vaccine coverage and identify factors associated with vaccination among forcibly displaced, pediatric populations.

Researchers conducted a review that provided updated evidence regarding the pneumococcal disease burden, the evolution of pneumococcal vaccines, and the latest immunization strategies.

Owner of Avant Pharmacy, and President of the Avant Institute of Clinical Pharmacy, Amina Abubakar, PharmD, AAHIVP, discusses how her work in the industry is reaching far beyond the pharmacy counter.

Researchers wanted to address the potential impact of pharmacist-led influenza immunization services on vaccine uptake in older adults living in Denmark.

Amina Abubakar, PharmD, AAHIVP, joined Drug Topics to discuss her career journey as an independent pharmacy owner and the ways in which she’s been able to grow her business.

Researchers investigated Norwegian pharmacists to understand their expertise, and potential knowledge gaps, regarding issues of epilepsy and treatment using antiseizure medication.

At the Total Pharmacy Solutions Summit Spring 2025 event, diagnostics experts Jenna Anderson and Amanda Wiley explored community pharmacists’ role in at-home testing.

Researchers developed, pilot-tested, and evaluated the feasibility of a telehealth electronic application that simulated pharmacists’ prescribing of contraceptives to adolescents and young adults.

Researchers conducted a systematic review to summarize research that has addressed social media’s impact on skin health promotion activities.

At the Total Pharmacy Solutions Summit Spring 2025, Ashley Keller, CPhT, discussed innovative ways to make pharmacy businesses thrive and, in turn, benefit patients.

SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.